JPS562969A - Cyclic peptide - Google Patents

Cyclic peptide

Info

Publication number
JPS562969A
JPS562969A JP7808879A JP7808879A JPS562969A JP S562969 A JPS562969 A JP S562969A JP 7808879 A JP7808879 A JP 7808879A JP 7808879 A JP7808879 A JP 7808879A JP S562969 A JPS562969 A JP S562969A
Authority
JP
Japan
Prior art keywords
formula
compound shown
compound
arginine
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7808879A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6241508B2 (https=
Inventor
Kenji Suzuki
Yusuke Sasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Grelan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grelan Pharmaceutical Co Ltd filed Critical Grelan Pharmaceutical Co Ltd
Priority to JP7808879A priority Critical patent/JPS562969A/ja
Publication of JPS562969A publication Critical patent/JPS562969A/ja
Publication of JPS6241508B2 publication Critical patent/JPS6241508B2/ja
Granted legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
JP7808879A 1979-06-22 1979-06-22 Cyclic peptide Granted JPS562969A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7808879A JPS562969A (en) 1979-06-22 1979-06-22 Cyclic peptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7808879A JPS562969A (en) 1979-06-22 1979-06-22 Cyclic peptide

Publications (2)

Publication Number Publication Date
JPS562969A true JPS562969A (en) 1981-01-13
JPS6241508B2 JPS6241508B2 (https=) 1987-09-03

Family

ID=13652084

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7808879A Granted JPS562969A (en) 1979-06-22 1979-06-22 Cyclic peptide

Country Status (1)

Country Link
JP (1) JPS562969A (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940709A (en) * 1984-11-02 1990-07-10 Fujisawa Pharmaceutical Co., Ltd. Piperazine compound as PAF-antagonist

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940709A (en) * 1984-11-02 1990-07-10 Fujisawa Pharmaceutical Co., Ltd. Piperazine compound as PAF-antagonist

Also Published As

Publication number Publication date
JPS6241508B2 (https=) 1987-09-03

Similar Documents

Publication Publication Date Title
RU99123619A (ru) Антагонисты gnrh, модифицированные в положениях 5 и 6
ES8300087A1 (es) Procedimiento para preparar amidas tetrapeptidas n-adamantano-sustituidas.
AU1448983A (en) Dynorphin amide analogs
MY125555A (en) Heptapeptide oxytocin analogues
KR860004081A (ko) 폴리펩티드의 제조방법
JPS5559152A (en) New peptides with physiological activity and their preparation
ES528211A0 (es) Metodo de preparar derivados de vasotocina
ES2106188T3 (es) Analogos de bombesina.
IL61098A0 (en) New peptides and a process for their preparation
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
AU671989B2 (en) Treatment of tropical spastic paresis with peptide T
ES8105969A1 (es) Procedimiento para preparar derivados fluorados de metil-be ta-alanina.
JPS57209270A (en) Proline derivative
BG103197A (bg) Антитромботични азациклоалкилалканоил пептиди и псевдопептиди
JPS562969A (en) Cyclic peptide
KR890701571A (ko) 4h-3, 1-벤즈옥사진-4-온 화합물 및 세린 프로테아제 억제를 위한 그의 약학 조성물
GB8906972D0 (en) Peptides
Johnson et al. A new carboxy-protecting group for peptide synthesis and its direct conversion into an activated ester suitable for peptide formation: 4-(methylthio) phenyl and 4-(methylsulphonyl) phenyl esters
JPS5225768A (en) Preparation of novel pentapeptides
GB1178149A (en) alpha-(N-Thiocarboxy)-Amino Acid Anhydrides
KR950032271A (ko) 아자펩티드 유도체
ZA882641B (en) Human rhinovirus peptides
RU97101435A (ru) Пептиды, обладающие антистрессорным, противосудорожным и нейропротекторным действием
YU64192A (sh) Analozi insulina
GB1525664A (en) Tripeptides derived from phenylalanine and histidine their preparation and use